Publication | Open Access
The Safety and Efficacy of the Repeated PRRT with [90Y]Y/[177Lu]Lu-DOTATATE in Patients with NET
18
Citations
25
References
2021
Year
The repeated therapy with [<sup>90</sup>Y]Y/[<sup>177</sup>Lu]Lu-DOTATATE is safe and effective for patients with disseminated, inoperable G1 and G2 neuroendocrine tumours.
| Year | Citations | |
|---|---|---|
Page 1
Page 1